| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000080 | Mitotic g1 phase | Affects phenotype | PMID:20020935; PMID:28035397; PMID:37467947 |
| GO:0000084 | Mitotic s phase | Affects phenotype | PMID:28035397; PMID:37467947 |
| GO:0000085 | Mitotic g2 phase | Affects phenotype | PMID:28035397 |
| GO:0000266 | Mitochondrial fission | Increases phenotype | PMID:31874198 |
| GO:0000902 | Cell morphogenesis | Affects phenotype | PMID:32142724 |
| GO:0001510 | Rna methylation | Affects phenotype | PMID:37269892 |
| GO:0001649 | Osteoblast differentiation | Increases phenotype | PMID:30731080 |
| GO:0001774 | Microglial cell activation | Increases phenotype | PMID:36308466 |
| GO:0001776 | Leukocyte homeostasis | Decreases phenotype | PMID:30081045 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:29115570; PMID:31874198 |
| GO:0001951 | Intestinal d-glucose absorption | Increases phenotype | PMID:22354675 |
| GO:0001954 | Positive regulation of cell-matrix adhesion | Decreases phenotype | PMID:28829631 |
| GO:0002027 | Regulation of heart rate | Affects phenotype | PMID:17107858 |
| GO:0002118 | Aggressive behavior | Increases phenotype | PMID:34728761 |
| GO:0002301 | Cd4-positive, alpha-beta intraepithelial t cell differentiation | Decreases phenotype | PMID:20109038 |
| GO:0002377 | Immunoglobulin production | Affects phenotype | PMID:15831097 |
| GO:0002449 | Lymphocyte mediated immunity | Affects phenotype | PMID:15831097 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:35498220; PMID:38180308 |
| GO:0002534 | Cytokine production involved in inflammatory response | Increases phenotype | PMID:34014775 |
| GO:0002761 | Regulation of myeloid leukocyte differentiation | Affects phenotype | PMID:28973681 |
| GO:0002923 | Regulation of humoral immune response mediated by circulating immunoglobulin | Affects phenotype | PMID:32276596 |
| GO:0003006 | Developmental process involved in reproduction | Decreases phenotype | PMID:32653800 |
| GO:0003014 | Renal system process | Decreases phenotype | PMID:33678412 |
| GO:0003073 | Regulation of systemic arterial blood pressure | Affects phenotype | PMID:28292314 |
| GO:0003084 | Positive regulation of systemic arterial blood pressure | Increases phenotype | PMID:19921116; PMID:23484121 |
| GO:0003093 | Regulation of glomerular filtration | Affects phenotype | PMID:25424620 |
| GO:0003094 | Glomerular filtration | Affects phenotype | PMID:19700501; PMID:33678412; PMID:26852280 |
| GO:0003104 | Positive regulation of glomerular filtration | Increases phenotype | PMID:31326826 |
| GO:0003872 | 6-phosphofructokinase activity | Decreases phenotype | PMID:34508822 |
| GO:0003954 | Nadh dehydrogenase activity | Decreases phenotype | PMID:32407874 |
| GO:0003993 | Acid phosphatase activity | Increases phenotype | PMID:35307918 |
| GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:30081045 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:16092086; PMID:35307918 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:30081045 |
| GO:0004111 | Creatine kinase activity | Decreases phenotype | PMID:21725498 |
| GO:0004129 | Cytochrome-c oxidase activity | Decreases phenotype | PMID:33038468; PMID:39547369 |
| GO:0004357 | Glutamate-cysteine ligase activity | Decreases phenotype | PMID:29630945 |
| GO:0004364 | Glutathione transferase activity | Decreases phenotype | PMID:30359721; PMID:31610155; PMID:39270966 |
| GO:0004457 | Lactate dehydrogenase activity | Decreases phenotype | PMID:34508822 |
| GO:0004575 | Sucrose alpha-glucosidase activity | Decreases phenotype | PMID:16092086 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:23424868; PMID:30738203; PMID:32407874; PMID:37415728 |
| GO:0004697 | Protein kinase c activity | Decreases phenotype | PMID:31843630 |
| GO:0004743 | Pyruvate kinase activity | Decreases phenotype | PMID:31647946 |
| GO:0004784 | Superoxide dismutase activity | Increases phenotype | PMID:23424868; PMID:29630945; PMID:30738203; PMID:31874198; PMID:35398025; PMID:35752206; PMID:37415728; PMID:40010429 |
| GO:0005243 | Gap junction channel activity | Decreases phenotype | PMID:33242459 |
| GO:0005391 | P-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:31874198 |
| GO:0005515 | Protein binding | Increases phenotype | PMID:29170096 |
| GO:0005757 | Mitochondrial permeability transition pore complex | Affects phenotype | PMID:31874198; PMID:35300571 |
| GO:0005776 | Autophagosome | Affects phenotype | PMID:36840722 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:25874871; PMID:34508822 |
| GO:0006020 | Inositol metabolic process | Affects phenotype | PMID:17450218 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:33038468; PMID:34508822 |
| GO:0006090 | Pyruvate metabolic process | Affects phenotype | PMID:29529432; PMID:34508822 |
| GO:0006096 | Glycolytic process | Decreases phenotype | PMID:36096218 |
| GO:0006119 | Oxidative phosphorylation | Decreases phenotype | PMID:36096218; PMID:39547369 |
| GO:0006264 | Mitochondrial dna replication | Decreases phenotype | PMID:31874198 |
| GO:0006281 | Dna repair | Affects phenotype | PMID:22466227; PMID:31769258 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:38700421 |
| GO:0006306 | Dna methylation | Decreases phenotype | PMID:24519525; PMID:28858830; PMID:38833407 |
| GO:0006325 | Chromatin organization | Decreases phenotype | PMID:30905827 |
| GO:0006497 | Protein lipidation | Increases phenotype | PMID:33242459 |
| GO:0006600 | Creatine metabolic process | Affects phenotype | PMID:19590687 |
| GO:0006606 | Protein import into nucleus | Increases phenotype | PMID:33080273 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:30081045; PMID:38180308 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:39461408 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:24881885; PMID:32407874; PMID:34165617; PMID:34508822; PMID:35307918; PMID:35752206; PMID:36642386; PMID:37676925; PMID:39032614; PMID:39276841; PMID:40010429 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:26989453; PMID:29630945; PMID:30359721; PMID:30476502; PMID:30738203; PMID:31874198 |
| GO:0006754 | Atp biosynthetic process | Decreases phenotype | PMID:31647946; PMID:31874198; PMID:32407874 |
| GO:0006813 | Potassium ion transport | Affects phenotype | PMID:33038468 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:31843630; PMID:39153536 |
| GO:0006878 | Cellular copper ion homeostasis | Affects phenotype | PMID:40010429 |
| GO:0006879 | Cellular iron ion homeostasis | Affects phenotype | PMID:39276841 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:15336320; PMID:28035397; PMID:29115570; PMID:29630945; PMID:30905827; PMID:30950269; PMID:31874198; PMID:32004626; PMID:32179164; PMID:33242459; PMID:37467947; PMID:40010429 |
| GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:31874198 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:29630945 |
| GO:0006959 | Humoral immune response | Affects phenotype | PMID:15831097 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:32142724; PMID:34508822 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:15336320; PMID:20025841; PMID:23578882; PMID:30081045 |
| GO:0006997 | Nucleus organization | Decreases phenotype | PMID:30905827 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:30905827; PMID:31874198; PMID:36642386; PMID:39276841; PMID:39547369 |
| GO:0007006 | Mitochondrial membrane organization | Decreases phenotype | PMID:33038468; PMID:37142061 |
| GO:0007009 | Plasma membrane organization | Decreases phenotype | PMID:30738203 |
| GO:0007029 | Endoplasmic reticulum organization | Decreases phenotype | PMID:30905827 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:38157908; PMID:38180308 |
| GO:0007268 | Chemical synaptic transmission | Affects phenotype | PMID:31785328 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:29549816; PMID:31647946; PMID:32142724; PMID:32976933; PMID:34508822; PMID:36484981 |
| GO:0007409 | Axonogenesis | Decreases phenotype | PMID:36096218 |
| GO:0007420 | Brain development | Decreases phenotype | PMID:16717205; PMID:20829427 |
| GO:0007601 | Visual perception | Decreases phenotype | PMID:27266277; PMID:31666078 |
| GO:0007605 | Sensory perception of sound | Decreases phenotype | PMID:23022869; PMID:27266277 |
| GO:0007610 | Behavior | Affects phenotype | PMID:20019913; PMID:31513824; PMID:21510976; PMID:30732589; PMID:31454729; PMID:34728761 |
| GO:0007611 | Learning or memory | Decreases phenotype | PMID:27936013; PMID:27936013; PMID:29476096; PMID:32058320 |
| GO:0007612 | Learning | Decreases phenotype | PMID:31539617; PMID:31539617; PMID:34742682; PMID:33223335; PMID:37244597; PMID:33978298; PMID:34742682; PMID:36308466; PMID:37244597; PMID:38160928; PMID:39947421 |
| GO:0007613 | Memory | Decreases phenotype | PMID:25141213; PMID:29301062; PMID:30090589; PMID:31539617; PMID:31539617; PMID:34742682; PMID:33223335; PMID:37244597; PMID:33978298; PMID:33978298; PMID:35367965; PMID:34742682; PMID:36652739; PMID:37244597; PMID:37415728; PMID:38160928; PMID:39947421 |
| GO:0007625 | Grooming behavior | Increases phenotype | PMID:35760230 |
| GO:0007631 | Feeding behavior | Affects phenotype | PMID:37676925 |
| GO:0008121 | Ubiquinol-cytochrome-c reductase activity | Decreases phenotype | PMID:33038468 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:31647946; PMID:33038468; PMID:39547369 |
| GO:0008152 | Metabolic process | Affects phenotype | PMID:29966840; PMID:31551411 |
| GO:0008177 | Succinate dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:31647946; PMID:33038468 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:39461408 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:30090589 |
| GO:0008217 | Regulation of blood pressure | Affects phenotype | PMID:18087585; PMID:33407552; PMID:20123609; PMID:20478760; PMID:25582168; PMID:39461408 |
| GO:0008219 | Cell death | Increases phenotype | PMID:23578882; PMID:23719929; PMID:31708536 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:24953315; PMID:29549816; PMID:32004626; PMID:34816377; PMID:37386098; PMID:38563870 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:37142061; PMID:37436718 |
| GO:0008542 | Visual learning | Decreases phenotype | PMID:30836164 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:31647946 |
| GO:0009060 | Aerobic respiration | Decreases phenotype | PMID:31756223 |
| GO:0009308 | Amine metabolic process | Affects phenotype | PMID:19590687 |
| GO:0010288 | Response to lead ion | Affects phenotype | PMID:19938001; PMID:23855546 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Affects phenotype | PMID:26115033; PMID:29481626; PMID:31119761; PMID:31636367; PMID:32734142 |
| GO:0010468 | Regulation of gene expression | Affects phenotype | PMID:32458983 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:36652739 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:25981801 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:22610977; PMID:22610977; PMID:24881885; PMID:25981801 |
| GO:0010996 | Response to auditory stimulus | Decreases phenotype | PMID:27266277 |
| GO:0014002 | Astrocyte development | Decreases phenotype | PMID:20829427 |
| GO:0015692 | Lead ion transport | Increases phenotype | PMID:23238610; PMID:30025905; PMID:34051273; PMID:34508822 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:29630945; PMID:30738203; PMID:31610155; PMID:31874198; PMID:32407874; PMID:34508822; PMID:35307918; PMID:35398025; PMID:35752206 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:30950269 |
| GO:0016079 | Synaptic vesicle exocytosis | Decreases phenotype | PMID:29029315 |
| GO:0016174 | Nad(p)h oxidase h2o2-forming activity | Increases phenotype | PMID:25596430 |
| GO:0016358 | Dendrite development | Decreases phenotype | PMID:31708536 |
| GO:0016477 | Cell migration | Decreases phenotype | PMID:38157908 |
| GO:0016573 | Histone acetylation | Increases phenotype | PMID:24291742 |
| GO:0017121 | Plasma membrane phospholipid scrambling | Increases phenotype | PMID:21482638 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:30081045; PMID:32407874; PMID:36484981; PMID:38700421 |
| GO:0018394 | Peptidyl-lysine acetylation | Decreases phenotype | PMID:31647946 |
| GO:0019695 | Choline metabolic process | Affects phenotype | PMID:19590687 |
| GO:0021778 | Oligodendrocyte cell fate specification | Increases phenotype | PMID:32458983 |
| GO:0022008 | Neurogenesis | Decreases phenotype | PMID:33978298 |
| GO:0022010 | Central nervous system myelination | Decreases phenotype | PMID:39150886 |
| GO:0030001 | Metal ion transport | Affects phenotype | PMID:28721440 |
| GO:0030097 | Hemopoiesis | Decreases phenotype | PMID:39461408 |
| GO:0030154 | Cell differentiation | Affects phenotype | PMID:37467947 |
| GO:0030182 | Neuron differentiation | Decreases phenotype | PMID:24519525; PMID:36096218; PMID:37467947 |
| GO:0030199 | Collagen fibril organization | Increases phenotype | PMID:33223335 |
| GO:0030220 | Platelet formation | Decreases phenotype | PMID:34083740 |
| GO:0030222 | Eosinophil differentiation | Increases phenotype | PMID:39461408 |
| GO:0030263 | Apoptotic chromosome condensation | Affects phenotype | PMID:30905827; PMID:31708536; PMID:38180308 |
| GO:0030282 | Bone mineralization | Increases phenotype | PMID:30731080 |
| GO:0030308 | Negative regulation of cell growth | Increases phenotype | PMID:37142061 |
| GO:0031175 | Neuron projection development | Affects phenotype | PMID:29301062; PMID:33080273; PMID:39947421 |
| GO:0031324 | Negative regulation of cellular metabolic process | Increases phenotype | PMID:34189835 |
| GO:0031394 | Positive regulation of prostaglandin biosynthetic process | Increases phenotype | PMID:25268557 |
| GO:0031966 | Mitochondrial membrane | Affects phenotype | PMID:33038468 |
| GO:0031987 | Locomotion involved in locomotory behavior | Decreases phenotype | PMID:35398025 |
| GO:0032042 | Mitochondrial dna metabolic process | Affects phenotype | PMID:30753999 |
| GO:0032469 | Endoplasmic reticulum calcium ion homeostasis | Affects phenotype | PMID:36308466 |
| GO:0032471 | Negative regulation of endoplasmic reticulum calcium ion concentration | Increases phenotype | PMID:25921245 |
| GO:0032616 | Interleukin-13 production | Increases phenotype | PMID:31921472 |
| GO:0032680 | Regulation of tumor necrosis factor production | Affects phenotype | PMID:31652851 |
| GO:0032729 | Positive regulation of type ii interferon production | Increases phenotype | PMID:33483752 |
| GO:0032760 | Positive regulation of tumor necrosis factor production | Increases phenotype | PMID:29028684; PMID:31652851 |
| GO:0032776 | Dna methylation on cytosine | Affects phenotype | PMID:33445541 |
| GO:0032790 | Ribosome disassembly | Increases phenotype | PMID:30905827 |
| GO:0032962 | Positive regulation of inositol trisphosphate biosynthetic process | Increases phenotype | PMID:25921245 |
| GO:0033555 | Multicellular organismal response to stress | Affects phenotype | PMID:22112310 |
| GO:0034101 | Erythrocyte homeostasis | Decreases phenotype | PMID:30081045 |
| GO:0034108 | Positive regulation of erythrocyte clearance | Increases phenotype | PMID:21482638 |
| GO:0034199 | Activation of protein kinase a activity | Decreases phenotype | PMID:22610977 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:30081045; PMID:32678766; PMID:36484981; PMID:36642386; PMID:37676925; PMID:39276841; PMID:40010429 |
| GO:0034599 | Cellular response to oxidative stress | Increases phenotype | PMID:32058320 |
| GO:0034650 | Cortisol metabolic process | Affects phenotype | PMID:24916609 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:26586927; PMID:28569757; PMID:30836164; PMID:35760230 |
| GO:0035633 | Maintenance of blood-brain barrier | Decreases phenotype | PMID:24431214 |
| GO:0035640 | Exploration behavior | Decreases phenotype | PMID:35760230 |
| GO:0036035 | Osteoclast development | Affects phenotype | PMID:26518054 |
| GO:0036050 | Peptidyl-lysine succinylation | Decreases phenotype | PMID:31647946 |
| GO:0036123 | Histone h3-k9 dimethylation | Increases phenotype | PMID:28712943 |
| GO:0036344 | Platelet morphogenesis | Decreases phenotype | PMID:39461408 |
| GO:0036444 | Calcium import into the mitochondrion | Decreases phenotype | PMID:24881885 |
| GO:0038061 | Nik/nf-kappab signaling | Increases phenotype | PMID:26518054 |
| GO:0040014 | Regulation of multicellular organism growth | Decreases phenotype | PMID:26715556 |
| GO:0040018 | Positive regulation of multicellular organism growth | Decreases phenotype | PMID:25224708 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:30090589; PMID:33223335; PMID:38797200 |
| GO:0042541 | Hemoglobin biosynthetic process | Decreases phenotype | PMID:22573942; PMID:23022869 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:25596430; PMID:35398025 |
| GO:0042593 | Glucose homeostasis | Decreases phenotype | PMID:22354675 |
| GO:0042670 | Retinal cone cell differentiation | Decreases phenotype | PMID:28050121 |
| GO:0042696 | Menarche | Affects phenotype | PMID:36729392 |
| GO:0042697 | Menopause | Affects phenotype | PMID:32832842 |
| GO:0042756 | Drinking behavior | Increases phenotype | PMID:31550440; PMID:37676925 |
| GO:0042775 | Mitochondrial atp synthesis coupled electron transport | Decreases phenotype | PMID:31756223 |
| GO:0043005 | Neuron projection | Decreases phenotype | PMID:33080273; PMID:38160928 |
| GO:0043046 | Dna methylation involved in gamete generation | Affects phenotype | PMID:26417717 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:20829427; PMID:25921245 |
| GO:0043197 | Dendritic spine | Affects phenotype | PMID:39947421 |
| GO:0043374 | Cd8-positive, alpha-beta t cell differentiation | Decreases phenotype | PMID:21241821 |
| GO:0043970 | Histone h3-k9 acetylation | Increases phenotype | PMID:27239543; PMID:28712943 |
| GO:0044030 | Regulation of dna methylation | Affects phenotype | PMID:26115033; PMID:33445541 |
| GO:0044062 | Regulation of excretion | Increases phenotype | PMID:23806787 |
| GO:0044237 | Cellular metabolic process | Affects phenotype | PMID:20020935; PMID:28035397; PMID:29115570; PMID:29957541; PMID:30476502; PMID:31610155; PMID:31843630; PMID:31874198; PMID:31874198; PMID:35300571; PMID:39032614; PMID:39547369; PMID:32004626; PMID:32142724; PMID:34508822; PMID:32344020; PMID:32344020; PMID:39947421; PMID:34165617; PMID:34508822; PMID:35300571; PMID:36484981; PMID:36642386; PMID:36925031; PMID:38157908; PMID:38700421; PMID:39032614; PMID:39276841; PMID:39547369; PMID:40010429 |
| GO:0044648 | Histone h3-k4 dimethylation | Increases phenotype | PMID:27239543 |
| GO:0044728 | Dna methylation or demethylation | Affects phenotype | PMID:33445541 |
| GO:0044838 | Cell quiescence | Increases phenotype | PMID:33483752; PMID:37436718 |
| GO:0045216 | Cell-cell junction organization | Decreases phenotype | PMID:36642386 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:33038468 |
| GO:0045780 | Positive regulation of bone resorption | Increases phenotype | PMID:23247522 |
| GO:0045919 | Positive regulation of cytolysis | Increases phenotype | PMID:34189835 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:30738203 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:33038468; PMID:34508822; PMID:36484981; PMID:39547369 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:35752206; PMID:37676925 |
| GO:0046323 | Glucose import | Decreases phenotype | PMID:31874198 |
| GO:0046415 | Urate metabolic process | Decreases phenotype | PMID:30081045 |
| GO:0046449 | Creatinine metabolic process | Decreases phenotype | PMID:30081045 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:10928693; PMID:10928693; PMID:20025841; PMID:20025841; PMID:30031113; PMID:32976933 |
| GO:0046501 | Protoporphyrinogen ix metabolic process | Affects phenotype | PMID:19938001 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:25268557 |
| GO:0046697 | Decidualization | Increases phenotype | PMID:32004626 |
| GO:0046850 | Regulation of bone remodeling | Affects phenotype | PMID:21839992 |
| GO:0046933 | Proton-transporting atp synthase activity, rotational mechanism | Decreases phenotype | PMID:39547369 |
| GO:0048143 | Astrocyte activation | Increases phenotype | PMID:34742682 |
| GO:0048714 | Positive regulation of oligodendrocyte differentiation | Increases phenotype | PMID:32458983 |
| GO:0048821 | Erythrocyte development | Increases phenotype | PMID:39461408 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Affects phenotype | PMID:35037767 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:30738203 |
| GO:0050667 | Homocysteine metabolic process | Affects phenotype | PMID:28789684 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:25288670 |
| GO:0050766 | Positive regulation of phagocytosis | Increases phenotype | PMID:21482638 |
| GO:0050801 | Monoatomic ion homeostasis | Affects phenotype | PMID:30090589 |
| GO:0050890 | Cognition | Decreases phenotype | PMID:15583371; PMID:16002379; PMID:17687454; PMID:17905657; PMID:19643133; PMID:20019913; PMID:21205584; PMID:22999658; PMID:27562236; PMID:28270159; PMID:31327061; PMID:31666078; PMID:21450073; PMID:26968381; PMID:25288670; PMID:35750750 |
| GO:0050974 | Detection of mechanical stimulus involved in sensory perception | Affects phenotype | PMID:32340109 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:37142061 |
| GO:0051170 | Import into nucleus | Increases phenotype | PMID:31539617 |
| GO:0051281 | Positive regulation of release of sequestered calcium ion into cytosol | Increases phenotype | PMID:25921245 |
| GO:0051402 | Neuron apoptotic process | Increases phenotype | PMID:33978298; PMID:37467947 |
| GO:0051462 | Regulation of cortisol secretion | Affects phenotype | PMID:26926653 |
| GO:0051480 | Regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:29170096 |
| GO:0051560 | Mitochondrial calcium ion homeostasis | Affects phenotype | PMID:36308466 |
| GO:0051561 | Positive regulation of mitochondrial calcium ion concentration | Increases phenotype | PMID:25921245 |
| GO:0051775 | Response to redox state | Decreases phenotype | PMID:30081045 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:30738203; PMID:31874198; PMID:32407874; PMID:33038468; PMID:35300571 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:29115570; PMID:36484981; PMID:37142061 |
| GO:0051913 | Regulation of synaptic plasticity by chemical substance | Affects phenotype | PMID:29939358 |
| GO:0051964 | Negative regulation of synapse assembly | Increases phenotype | PMID:28050121 |
| GO:0055065 | Metal ion homeostasis | Increases phenotype | PMID:11450370; PMID:12173534; PMID:19847775; PMID:21241821; PMID:22647239; PMID:24315962; PMID:29452138; PMID:30081045; PMID:32208856 |
| GO:0055069 | Zinc ion homeostasis | Affects phenotype | PMID:35398025 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:30905827 |
| GO:0060047 | Heart contraction | Affects phenotype | PMID:18091001 |
| GO:0060221 | Retinal rod cell differentiation | Decreases phenotype | PMID:28050121 |
| GO:0060314 | Regulation of ryanodine-sensitive calcium-release channel activity | Affects phenotype | PMID:29170096 |
| GO:0060322 | Head development | Decreases phenotype | PMID:12641193 |
| GO:0060348 | Bone development | Decreases phenotype | PMID:26518054; PMID:30696509 |
| GO:0060996 | Dendritic spine development | Decreases phenotype | PMID:27936013; PMID:39947421 |
| GO:0061000 | Negative regulation of dendritic spine development | Increases phenotype | PMID:29476096 |
| GO:0061092 | Positive regulation of phospholipid translocation | Decreases phenotype | PMID:21482638 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:32232643; PMID:36484981 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:34165617; PMID:38180308 |
| GO:0070444 | Oligodendrocyte progenitor proliferation | Decreases phenotype | PMID:39150886 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:16507456; PMID:26612503; PMID:32678766; PMID:34816377; PMID:35398025; PMID:36484981; PMID:37415728; PMID:38180308; PMID:39547369 |
| GO:0070997 | Neuron death | Increases phenotype | PMID:36308466 |
| GO:0071277 | Cellular response to calcium ion | Increases phenotype | PMID:29170096 |
| GO:0071284 | Cellular response to lead ion | Increases phenotype | PMID:32458983 |
| GO:0071461 | Cellular response to redox state | Increases phenotype | PMID:31756223 |
| GO:0071480 | Cellular response to gamma radiation | Affects phenotype | PMID:31769258 |
| GO:0071763 | Nuclear membrane organization | Decreases phenotype | PMID:30905827 |
| GO:0071971 | Extracellular exosome assembly | Increases phenotype | PMID:36840722 |
| GO:0072346 | Cadpr-sensitive calcium-release channel activity | Increases phenotype | PMID:29170096 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:28035397; PMID:32407874; PMID:35300571; PMID:36642386; PMID:38700421; PMID:39032614; PMID:39276841; PMID:40010429 |
| GO:0080182 | Histone h3-k4 trimethylation | Increases phenotype | PMID:28712943 |
| GO:0090090 | Negative regulation of canonical wnt signaling pathway | Increases phenotype | PMID:37436718 |
| GO:0090648 | Response to environmental enrichment | Decreases phenotype | PMID:35398025 |
| GO:0097062 | Dendritic spine maintenance | Decreases phenotype | PMID:30738087; PMID:38160928 |
| GO:0097119 | Postsynaptic density protein 95 clustering | Decreases phenotype | PMID:26660114 |
| GO:0097205 | Renal filtration | Increases phenotype | PMID:16581550 |
| GO:0097707 | Ferroptosis | Increases phenotype | PMID:36642386 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:29549816; PMID:36484981 |
| GO:0098532 | Histone h3-k27 trimethylation | Increases phenotype | PMID:27239543; PMID:28712943; PMID:29301062 |
| GO:0098727 | Maintenance of cell number | Affects phenotype | PMID:30836164; PMID:30950269 |
| GO:0098771 | Inorganic ion homeostasis | Affects phenotype | PMID:22923205 |
| GO:0098801 | Regulation of renal system process | Decreases phenotype | PMID:19921116 |
| GO:0140657 | Atp-dependent activity | Decreases phenotype | PMID:35307918 |
| GO:0150104 | Transport across blood-brain barrier | Affects phenotype | PMID:36641952 |
| GO:0150195 | Transport across blood-cerebrospinal fluid barrier | Affects phenotype | PMID:36642386 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:39579145 |
| GO:1900272 | Negative regulation of long-term synaptic potentiation | Increases phenotype | PMID:29476096 |
| GO:1901216 | Positive regulation of neuron death | Increases phenotype | PMID:18353414 |
| GO:1901318 | Negative regulation of flagellated sperm motility | Affects phenotype | PMID:32976933 |
| GO:1901612 | Cardiolipin binding | Decreases phenotype | PMID:35300571 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:30031113; PMID:30081045; PMID:31756223 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Increases phenotype | PMID:32976933 |
| GO:1902003 | Regulation of amyloid-beta formation | Affects phenotype | PMID:22313790 |
| GO:1902034 | Negative regulation of hematopoietic stem cell proliferation | Increases phenotype | PMID:33483752 |
| GO:1902237 | Positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | Increases phenotype | PMID:24791885 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:31756223 |
| GO:1902600 | Proton transmembrane transport | Affects phenotype | PMID:33038468 |
| GO:1902882 | Regulation of response to oxidative stress | Affects phenotype | PMID:23479318 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:20020935; PMID:28035397; PMID:37467947 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Affects phenotype | PMID:30476502; PMID:30738203; PMID:30905827; PMID:31610155; PMID:31647946; PMID:31874198 |
| GO:1903427 | Negative regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:34189835 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:24881885; PMID:36308466; PMID:37142061 |
| GO:1903561 | Extracellular vesicle | Increases phenotype | PMID:34044057 |
| GO:1903703 | Enterocyte differentiation | Affects phenotype | PMID:38563870 |
| GO:1905037 | Autophagosome organization | Affects phenotype | PMID:36840722 |
| GO:1905456 | Regulation of lymphoid progenitor cell differentiation | Affects phenotype | PMID:32428222 |
| GO:1905457 | Negative regulation of lymphoid progenitor cell differentiation | Increases phenotype | PMID:32428222 |
| GO:1905603 | Regulation of blood-brain barrier permeability | Decreases phenotype | PMID:20829427 |
| GO:1990051 | Activation of protein kinase c activity | Decreases phenotype | PMID:22610977 |
| GO:1990079 | Cartilage homeostasis | Affects phenotype | PMID:21839992 |
| GO:1990182 | Exosomal secretion | Increases phenotype | PMID:36840722 |
| GO:2000379 | Positive regulation of reactive oxygen species metabolic process | Increases phenotype | PMID:36308466 |
| GO:2000403 | Positive regulation of lymphocyte migration | Increases phenotype | PMID:36220500 |
| GO:2000617 | Positive regulation of histone h3-k9 acetylation | Increases phenotype | PMID:29301062 |
| GO:2000653 | Regulation of genetic imprinting | Affects phenotype | PMID:26115033 |
| GO:2000774 | Positive regulation of cellular senescence | Increases phenotype | PMID:39579145 |
| GO:2000808 | Negative regulation of synaptic vesicle clustering | Increases phenotype | PMID:35367965 |
| GO:2000872 | Positive regulation of progesterone secretion | Decreases phenotype | PMID:25981801 |
| GO:2001057 | Reactive nitrogen species metabolic process | Affects phenotype | PMID:32407874 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.